4.56% -0.34

Cyclacel Pharmaceuticals Inc (CYCC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Cyclacel Pharmaceuticals Inc Azioni (CYCC) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	0.01	0.004
Operating Expenses	73.85% 1.317	5.036	1.828	2.187	3.648
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	73.85% -1.317	-5.036	-1.828	-2.177	-3.644
Net Interest Income/Expense	66.67% 0.002	0.006	-	-	-
Nonoperating Income/Loss	99.98% 0.001	4.955	-0.03	0.01	-0.025
Income/Loss From Continuing Operations Before Tax	1,525% -1.316	-0.081	-1.858	-2.167	-3.669
Income Tax Expense/Benefit	0.002	-	1.194	-0.21	-0.412
Income/Loss From Continuing Operations After Tax	1,527% -1.318	-0.081	-3.052	-1.957	-3.257
Net Income/Loss	1,527% -1.318	-0.081	-3.052	-1.957	-3.257
Preferred Stock Dividends And Other Adjustments	0.02	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Earnings Per Share	-0.98	-	-	-	-
Diluted Earnings Per Share	-0.98	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.02	-	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%